UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): July 9, 2010
IMARX
THERAPEUTICS, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-33043
|
|
86-0974730
|
(State
or other Jurisdiction of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
|
|
|
6860
Lexington Avenue, Suite 120
Los
Angeles, CA
|
|
90038
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (323) 790-1717
|
|
(Former
name or former address if changed since last
report.)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 5.07
Submission of Matters to a Vote of Security Holders.
On July
9, 2010 ImaRx Therapeutics, Inc. (“ImaRx” or the “Company”) held a Special
Meeting of Stockholders. At the special meeting, the stockholders of
ImaRx approved the reincorporation of the Company in the State of Nevada by the
following vote:
Votes
For:
|
|
77,114,506
|
Votes
Against:
|
|
6000
|
Abstentions:
|
|
759
|
Broker
Non-Votes:
|
|
0
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: July
14, 2010
|
IMARX
THERAPEUTICS, INC.
|
|
|
|
|
|
|
By:
|
/s/
Edward Sylvan
|
|
|
|
Edward
Sylvan
|
|
|
|
Chief
Executive Officer
|
|
|
|
|
|